SNDX
Syndax Pharmaceuticals Inc
Price:  
14.94 
USD
Volume:  
1,867,621.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SNDX WACC - Weighted Average Cost of Capital

The WACC of Syndax Pharmaceuticals Inc (SNDX) is 9.8%.

The Cost of Equity of Syndax Pharmaceuticals Inc (SNDX) is 9.85%.
The Cost of Debt of Syndax Pharmaceuticals Inc (SNDX) is 5.00%.

Range Selected
Cost of equity 7.90% - 11.80% 9.85%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.9% - 11.8% 9.8%
WACC

SNDX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.88 1.24
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 11.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0 0
Cost of debt 5.00% 5.00%
After-tax WACC 7.9% 11.8%
Selected WACC 9.8%